Herbas VPB

Print
EN | LT
LT - USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF CANCER RADIOTHERAPY
EN - USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF CANCER RADIOTHERAPY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/513 (2006.01)
A61K 38/465 (2013.01)
A61K 31/675 (2006.01)
A61K 45/06 (2013.01)
C12Y 301/21001 (2013.01)
A61K 31/704 (2006.01)
C12Y 301/22001 (2013.01)
A61K 31/7048 (2006.01)
A61K 31/7068 (2006.01)
A61K 31/513 (2013.01)
A61K 38/46 (2006.01)
A61K 31/675 (2013.01)
A61K 45/06 (2006.01)
A61K 31/704 (2013.01)
A61P 35/00 (2006.01)
A61K 31/7048 (2013.01)
A61P 43/00 (2006.01)
A61K 31/7068 (2013.01)
A61N 5/10 (2006.01)
A61P 35/00 (2018.01)
A61P 43/00 (2018.01)
A61N2005/1098 (2013.01)
European patent
(11) Number of the document 3878462
(13) Kind of document T
(96) European patent application number 21168707.4
Date of filing the European patent application 2015-10-29
(97) Date of publication of the European application 2021-09-15
(45) Date of publication and mention of the grant of the patent 2025-02-26
(46) Date of publication of the claims translation
Inventors
(72)
GENKIN, Dmitry Dmitrievich , RU
TETS, Georgy Viktorovich , RU
TETS, Viktor Veniaminovich , RU
Grantee
(73) CLS Therapeutics Limited , Frances House, Sir William Place St. Peter Port, Guernsey, Channel Islands, GY1 1GX, GG
Title
(54) USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF CANCER RADIOTHERAPY
  USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF CANCER RADIOTHERAPY